WHO “Remdesivir has no effect” … Quarantine authorities “should review treatment guidelines as is”

After taking remdesivir, a new treatment for coronavirus infection (Corona 19), 11 side effects were found in Korea.

Quarantine authorities will closely review the results of a World Health Organization (WHO) study indicating that remdesivir is not effective, but is not at the stage of changing treatment guidelines.

Kwon Joon-wook, deputy director of the Centers for Disease Control and Prevention at the Centers for Disease Control and Prevention (Bang Dae-bon), held a regular briefing for Corona 19 at the Center for Disease Control. Diseases in Osong, Chungbuk on the afternoon of 17.

Regarding the current status of remdesivir administration in Korea, 618 patients from 63 hospitals were administered. “There have been 11 reports of side effects related to remdesivir administration so far,” said Seo Kyung-won, head of the Drug Review Division of the Korea Food and Drug Administration. “It was a known side effect in clinical trials. So far there have been no serious or dangerous side effects.” According to foreign media, on the 15th (local time), in a solidarity experiment carried out by the WHO with 11,266 patients hospitalized for COVID -19, remdesivir determined the length of stay in. There are reports that it cannot reduce or reduce the mortality rate.

The study was conducted in more than 500 medical institutions in 30 countries.

Deputy General Manager Kwon explained, “A final expert review is still needed” and said: “At this time, we believe there is no need to change or improve home treatment guidelines.”

Korea supplies remdesivir only to seriously ill patients who need oxygen.

Deputy Director General Kwon said: “If there is a change in the guidelines from domestic and foreign experts, we will carefully review it once more,” he said.

It is also known that the President of the United States, Donald Trump, was treated with a ‘cocktail therapy’ that combines various treatments when infected with Corona 19.